Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1988
A controlled clinical trial was conducted at eight participating centers between January 1, 1988, and March 31, 1991. Patients were randomly assigned to an intravenous immune globulin group or a control group. There were two phases to the study (see below). During phase 1 the control infants received infusions of placebo. During phase 2 the control infants received no infusion therapy.
Epistemonikos ID: f1b4cabb2d49cde69755cb38805d53bc39db2029
First added on: May 05, 2024